CivaTech Oncology, Inc. specializes in innovative localized radiation therapy products designed to enhance the effectiveness and safety of low dose rate (LDR) brachytherapy. Their flagship products, CivaSheet® and CivaString®, utilize proprietary polymer encapsulated source technology, which allows for a more homogeneous dose distribution while minimizing trauma to surrounding tissues. CivaSheet® is notable for being the only FDA-cleared, unidirectional, planar brachytherapy source that is flexible and bioabsorbable, making it a unique option for treating various solid tumors. CivaString® serves as a linear, polymer-encapsulated LDR source, specifically designed for localized treatment of solid tumors, further streamlining the procedure and reducing the number of needles required for effective radiation delivery.

Additionally, CivaTech offers CivaDerm™, a temporary radiation therapy product intended for intraoperative or surface radiation treatment of skin cancer and other lesions. The integration of these products into existing clinical workflows is seamless, beginning with imaging modalities and extending through treatment planning to post-implant dosimetry. CivaTech's commitment to safety and efficacy is underscored by their compliance with FDA guidelines and international standards, as well as their licenses with the Nuclear Regulatory Commission for research and product distribution. Overall, CivaTech Oncology aims to provide cancer patients with advanced treatment options that prioritize quality of life and improved outcomes.

United States

CivaTech Oncology® designs innovative products that bring meaningful improvements to low dose rate brachytherapy. The CivaString® and CivaSheet™ can substantially reduce procedure time, provide homogeneous dose distribution and minimize trauma. Customizable CivaTech products ensure that radiation oncologists can deliver individualized, targeted therapy to treat cancer. 

http://www.civatechoncology.com/

CivaTech Oncology, Inc.

Company Details